Needham Initiates Coverage On iRadimed with Hold Rating
Needham analyst David Saxon initiates coverage on iRadimed (NASDAQ:IRMD) with a Hold rating.
Stocks · News reference
Filed: 2026-08-18 AccNo: 0001628280-26-057617 Size: 337 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Needham analyst David Saxon initiates coverage on iRadimed (NASDAQ:IRMD) with a Hold rating.